Correlation Between Akme Fintrade and Aarey Drugs

Can any of the company-specific risk be diversified away by investing in both Akme Fintrade and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akme Fintrade and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akme Fintrade India and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on Akme Fintrade and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akme Fintrade with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akme Fintrade and Aarey Drugs.

Diversification Opportunities for Akme Fintrade and Aarey Drugs

0.79

Correlation Coefficient

Akme Fintrade  Aarey Drugs

Poor diversification

The 3 months correlation between Akme and Aarey is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Akme Fintrade India and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and Akme Fintrade is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akme Fintrade India are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of Akme Fintrade i.e., Akme Fintrade and Aarey Drugs go up and down completely randomly.

Pair Corralation between Akme Fintrade and Aarey Drugs

Assuming the 90 days trading horizon Akme Fintrade India is expected to generate 1.36 times more return on investment than Aarey Drugs. However, Akme Fintrade is 1.36 times more volatile than Aarey Drugs Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Aarey Drugs Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest  9,424  in Akme Fintrade India on December 24, 2024 and sell it today you would lose (2,176) from holding Akme Fintrade India or give up 23.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Akme Fintrade India  vs.  Aarey Drugs Pharmaceuticals

Akme Fintrade India

Risk-Adjusted Performance

Very Weak

Over the last 90 days Akme Fintrade India has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Aarey Drugs Pharmace

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Akme Fintrade and Aarey Drugs

The main advantage of trading using opposite Akme Fintrade and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akme Fintrade position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.

The idea behind Akme Fintrade India and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.